With 350+ participants representing the core of China’s market, the Biopharma Development & Production Week is back to spur industry learning, showcase innovation and enable business contacts. With 3 co located conferences, 70+ speakers and over 60 technical and commercial sessions, this is without doubt the only forum with demonstrated value add for participants.
Against the bedrock of emerging and disruptive technologies, new generation facilities and continuous process improvement, participants will get quality practical information that enables them to develop advance capabilities in developing and manufacturing cell lines, biosimilars, biobetters, antibodies, vaccines and novel biologics.
2017 Attendees List
Partnership and Profile Building Opportunities are Now Available!
Contact us today to find out how you can position your company as a market leader at this event, and to explore the range of branding and marketing opportunities available.
Vice President, Manufacturing, Innovent Biologics, China
Managing Partner, Quadria Capital Investment Management Pte Ltd, Singapore
CIO, livzon Pharmaceutical Group, China
Chief Operating Officer, Valitacell, Ireland
Head of Global Distribution, Solentim
Dr Zhang Peiqing
Analytical Science and Technology Coordinator, Novartis
Professor, Department of Chemistry and Chemical Biology Faculty Fellow, Barnett Institute of Chemical and Biological Analysis Northeastern University, Boston, Massachusetts
Dr. John Yan
Applications Scientist, ProZyme
Hung Fai Poon
Chief Scientific Officer, Zhejiang Hisun Pharmaceutical Co., Ltd, China
Prof. David James
University of Sheffield
Ng Say Kong
Staff Scientist, Animal Cell Technology 2, Bioprocessing Technology Institute, A*STAR
Vice-President, Shenogen Pharma Group, China
Vice President, Zhejiang Doer Biologics Co.
VP & Site Head of Manufacturing, Wuxi AppTec, China
Dr. Jinyou Zhang
Senior Vice President/Head, Bio Development and Manufacturing, BeiGene Co. Ltd., China
Barbara A. Paldus, Ph.D.
Vice President & General Manager, Finesse, part of Thermo Fisher Scientific, U.S.
President & CEO, Kunshan Zotek Kinglai Co. Ltd. U.K.
Managing Director of Microbial Solutions, Greater China Region, Charles River Laboratories
Dr Yvan Ruland
Technology Manager Biopharma, Novasep, China
M.Sc. Vice President Head of CMC General Manager, Generon Beijing, China
Former Director, Quality Assurance, Amgen Singapore
Head of QC Laboratory 2 & Head of Microbial Control Team, WuXi Biologics, China
Dr. Dennis Yu Xia
Vice President of Manufacturing and Quality, Akeso Bio, China
Dr. John Zeng
Executive Vice President, Bioprocess Development & Pilot Plant Manufacturing, Shanghai Zerun Biotech Co Ltd, China
Head of Bioprocess, ZaiLab, Ltd.
Business Development Manager, Pall Life Sciences, UK
Dr. Christopher J. Hickey
Senior Director Government Affairs, Market Access & Communications, Pfizer
Dr. Scott Liu
President and CEO, Shanghai Henlius Biotech Inc.
Dr. Lutz Hilbrich
Head Strategic Task Force Biologics, Sanofi
Assistant Director, WuXi Biologics
Vice Director, Drug Research Institutes, Biopharmaceutical Institute, Jiangsu Aosaikang Pharmaceutical Co Ltd, China
Dr. Jacqueline Ming Liu
Vice President, TOT Biopharma, China
Dr Qiwei Wu
Ph.D, Vice President of Process Development and Manufacturing, Livzon Mabpharma
Dr Amy Hong Que
Vice President - Quality, Innovent Biologics
Chief Medical Officer, Shanghai Fosun Pharma
Prof. Dr. Florian Turk
Head Global Payor Marketing, Sales and Relations, Sandoz Biopharmaceuticals Sandoz International GmbH, Germany
Associate Vice President, Division of Project Development, Mycenax Biotech Inc., Taiwan
Vice President of Business Development, Samsung Bioepis, Korea
Dr. Xin Zhang
Head of Global Clinical Operations and Affairs, Shanghai Henlius Biotech Co Ltd, China
Director, Product Development, Zumutor Biologics, India
Team Leader of R&D CMC/PM, Celltrion R&D, Korea
General Manager - Business Development & Licensing, Intas Pharmaceuticals, India
Senior Vice President and Chief Medical Officer - Global Clinical Operations and Affairs, Shanghai Henlius Biotech Co Ltd, China
Dr Jun Yuan
Vice President, Quacell Biotech, China
SVP, Process & Product Development, Hangzhou JUST Biotherapeutics Co., Ltd., China
Director of Cell Line Development, WuXi Biologics, China
Head of Cell Line Development, JHL Biotech, Taiwan
Senior Principal Scientist/Group Leader, Cell Line Development, Bioprocess R&D, Pfizer Inc, USA
Associate Director – Cell Line Engineering and Development, Shanghai Hengrui Pharmaceutical, China
Sai Ling Liu
Chief Scientific Officer, Surfer Biotech, China
Vice President of CMC, Generon Corpoation (Shanghai) Limited, China
Dr. Li Shi
Chief Executive Officer, Shanghai Zerun Biotech Co. Ltd
China Biosimilars Regulation Publishing Manager, Pfizer
President, I-Mab Biopharma, China
Ph.D. VP of Process Development (Wuhan), JHL BioTech, China
Sr. Global Technology Manager, JSR Life Sciences
Dr. Frank Ye
SVP of Manufacturing and Quality, Hangzhou Just Biotherapeutics Co., Ltd., China
Director of Operations, Charles River Laboratories, U.S.
Dr. Bin Wang
Head of Business Development, Boehringer Ingelheim Biopharmaceuticals, China
President, Wanbang Biopharmaceuticals Co., Ltd, China
Still have a question?